Page last updated: 2024-09-02

hydroxycotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol

hydroxycotinine has been researched along with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol in 5 studies

Compound Research Comparison

Studies
(hydroxycotinine)
Trials
(hydroxycotinine)
Recent Studies (post-2010)
(hydroxycotinine)
Studies
(4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol)
Trials
(4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol)
Recent Studies (post-2010) (4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol)
200209920015120

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benowitz, NL; Calfee, CS; Eisner, MD; Goniewicz, ML; Havel, C; Hsieh, SJ; Jacob, P; Matthay, MA; Ware, LB; Yu, L1
Benowitz, NL; Carmella, SG; Hecht, SS; Lerman, CE; Pinto, AG; Strasser, AA; Tang, KZ; Tyndale, RF1
Benowitz, NL; Dempsey, D; Goniewicz, ML; Jacob, P; St Helen, G; Wilson, M1
Benowitz, NL; Hoh, E; Hovell, MF; Jacob, P; Khan, AM; Matt, GE; Northrup, TF; Stotts, AL1
Addo, N; Ahluwalia, JS; Benowitz, NL; Cox, LS; Gregorich, SE; PĂ©rez-Stable, EJ; St Helen, G; Tyndale, RF1

Other Studies

5 other study(ies) available for hydroxycotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol

ArticleYear
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.
    Critical care medicine, 2011, Volume: 39, Issue:1

    Topics: Academic Medical Centers; Adult; Aged; Biomarkers; Cohort Studies; Cotinine; Critical Illness; Female; Humans; Male; Middle Aged; Nitrosamines; Prevalence; Pyridines; Reference Values; Risk Assessment; Sensitivity and Specificity; Smoking; Statistics, Nonparametric; Tennessee; Tobacco Smoke Pollution

2011
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Biomarkers; Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Prognosis; Pyridines; Risk Assessment; Smoking; Survival Rate; Young Adult

2011
Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers.
    Chemical research in toxicology, 2012, Apr-16, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Cotinine; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Kinetics; Male; Middle Aged; Nicotine; Nitrosamines; Poland; Polycyclic Aromatic Hydrocarbons; Pyridines; ROC Curve; Smoking; Tandem Mass Spectrometry; United States; Young Adult

2012
Thirdhand smoke contamination in hospital settings: assessing exposure risk for vulnerable paediatric patients.
    Tobacco control, 2016, Volume: 25, Issue:6

    Topics: Carcinogens; Cotinine; Environmental Exposure; Environmental Monitoring; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Nicotine; Nitrosamines; Pregnancy; Tobacco Smoke Pollution

2016
Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.
    Journal of the National Medical Association, 2019, Volume: 111, Issue:5

    Topics: Adult; Age Factors; Aged; Biomarkers; Black or African American; Carcinogens; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Sex Factors; Smoking; Tobacco Products; Tobacco Use Disorder; Young Adult

2019